MedTrace Logo

PCV13 in Non-pregnant Papua New Guinean Women

NCT04183322 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-12-17

No results posted yet for this study

Summary

This is an observational study to determine the reactogenicity and immunogenicity of pneumococcal conjugate vaccine in non-pregnant women of reproductive age in Papua New Guinea.

Conditions

  • Pneumococcal Infections

Interventions

BIOLOGICAL

13-valent pneumococcal conjugate vaccine

Sponsors & Collaborators

  • Papua New Guinea Institute of Medical Research

    collaborator OTHER_GOV

  • Telethon Kids Institute

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-10
Primary Completion
2016-09-14
Completion
2018-04-10

Countries

  • Papua New Guinea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04183322 on ClinicalTrials.gov